Notice of Intent to Award a Sole Source Contract - FDA1179059

The Food and Drug Administration intends to make a sole source three (3) year IDIQ award to Illumina, Inc. for sequencing reagents required for the MiSeq, NextSeq and HiSeq Instruments. The MiSeq, NextSeq and HiSeq instruments use an all-inclusive reagent cartridge system that is specifically designed to deliver the reagents necessary for cluster generation, sequencing, and paired-end chemistry. The required reagents are specifically produced by the manufacturer (Illumina).

The period of performance will be for a total of 36 months and an IDIQ type of contract is anticipated. The NAICS Code for this action is 325413 - In-Vitro Diagnostic Substance Manufacturing.. This procurement is made under the authority of 10 USC 2304(c) (1) - only one responsible source. This is a notice of intent to issue this solicitation on a sole source basis. This notice of intent is not a solicitation for competitive proposals. Any other firm desiring consideration must fully identify their interest and capability to provide these items by submitting a capability statement to Janice Heard at [email protected] no later than July 21, 2017. A determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. The projected award date is August 31, 2017.